Soaring healthcare costs show little sign of slowing in 2024, with concerns growing about the affordability of medications and medical services.
Ellen Kelsay
Advertisement
Articles by Ellen Kelsay
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
2
How MBA Graduates Can Break into Competitive Industries in 2026: 4 Practical Steps
3
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
4
Pharmaceutical Executive Daily: FDA Approves Simtriyo
5